NovoCure: Q1 Earnings Insights

Comments
Loading...

NovoCure NVCR reported its Q1 earnings results on Thursday, May 4, 2023 at 07:00 AM.

Here's what investors need to know about the announcement.

Earnings

NovoCure missed estimated earnings by 56.25%, reporting an EPS of $-0.5 versus an estimate of $-0.32.

Revenue was down $15.37 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.06 which was followed by a 1.67% drop in the share price the next day.

Here's a look at NovoCure's past performance:

Quarter Q4 2022 Q3 2022 Q2 2022 Q1 2022
EPS Estimate -0.30 -0.26 -0.15 -0.18
EPS Actual -0.36 -0.25 -0.23 -0.04
Revenue Estimate 128.25M 131.94M 134.99M 134.08M
Revenue Actual 128.43M 131.00M 140.87M 137.55M

To track all earnings releases for NovoCure visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise

Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!